108 related articles for article (PubMed ID: 21875681)
1. The neuronal NO synthase participation in the peripheral antinociception mechanism induced by several analgesic drugs.
Romero TR; Resende LC; Duarte ID
Nitric Oxide; 2011 Nov; 25(4):431-5. PubMed ID: 21875681
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the L-arginine/nitric oxide/cyclic guanosine monophosphate pathway in peripheral antinociception induced by N-palmitoyl-ethanolamine in rats.
Romero TR; Galdino GS; Silva GC; Resende LC; Perez AC; Cortes SF; Duarte ID
J Neurosci Res; 2012 Jul; 90(7):1474-9. PubMed ID: 22411529
[TBL] [Abstract][Full Text] [Related]
3. Ketamine activates the L-arginine/Nitric oxide/cyclic guanosine monophosphate pathway to induce peripheral antinociception in rats.
Romero TR; Galdino GS; Silva GC; Resende LC; Perez AC; Côrtes SF; Duarte ID
Anesth Analg; 2011 Nov; 113(5):1254-9. PubMed ID: 21788321
[TBL] [Abstract][Full Text] [Related]
4. Ang-(1-7) activates the NO/cGMP and ATP-sensitive K+ channels pathway to induce peripheral antinociception in rats.
Costa A; Galdino G; Romero T; Silva G; Cortes S; Santos R; Duarte I
Nitric Oxide; 2014 Feb; 37():11-6. PubMed ID: 24361899
[TBL] [Abstract][Full Text] [Related]
5. CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system.
Romero TR; Resende LC; Guzzo LS; Duarte ID
Anesth Analg; 2013 Feb; 116(2):463-72. PubMed ID: 23302980
[TBL] [Abstract][Full Text] [Related]
6. Tingenone, a pentacyclic triterpene, induces peripheral antinociception due to NO/cGMP and ATP-sensitive K(+) channels pathway activation in mice.
de Carvalho Veloso C; Rodrigues VG; Ferreira RC; Duarte LP; Klein A; Duarte ID; Romero TR; de Castro Perez A
Eur J Pharmacol; 2015 May; 755():1-5. PubMed ID: 25748602
[TBL] [Abstract][Full Text] [Related]
7. alpha(2)-Adrenoceptor agonist xylazine induces peripheral antinociceptive effect by activation of the L-arginine/nitric oxide/cyclic GMP pathway in rat.
Romero TR; Duarte ID
Eur J Pharmacol; 2009 Jun; 613(1-3):64-7. PubMed ID: 19389395
[TBL] [Abstract][Full Text] [Related]
8. The synthetic peptide PnPP-19 induces peripheral antinociception via activation of NO/cGMP/K
Freitas AC; Silva GC; Pacheco DF; Pimenta AM; Lemos VS; Duarte ID; de Lima ME
Nitric Oxide; 2017 Apr; 64():31-38. PubMed ID: 28087360
[TBL] [Abstract][Full Text] [Related]
9. delta-Opioid receptor agonist SNC80 elicits peripheral antinociception via delta(1) and delta(2) receptors and activation of the l-arginine/nitric oxide/cyclic GMP pathway.
Pacheco DF; Reis GM; Francischi JN; Castro MS; Perez AC; Duarte ID
Life Sci; 2005 Nov; 78(1):54-60. PubMed ID: 16135369
[TBL] [Abstract][Full Text] [Related]
10. Noradrenaline activates the NO/cGMP/ATP-sensitive K(+) channels pathway to induce peripheral antinociception in rats.
Romero TR; Guzzo LS; Perez AC; Klein A; Duarte ID
Nitric Oxide; 2012 Mar; 26(3):157-61. PubMed ID: 22330728
[TBL] [Abstract][Full Text] [Related]
11. TRPA1, NMDA receptors and nitric oxide mediate mechanical hyperalgesia induced by local injection of magnesium sulfate into the rat hind paw.
Srebro DP; Vučković SM; Savić Vujović KR; Prostran MŠ
Physiol Behav; 2015 Feb; 139():267-73. PubMed ID: 25449407
[TBL] [Abstract][Full Text] [Related]
12. Peripheral neuronal nitric oxide synthase activity mediates the antinociceptive effect of Crotalus durissus terrificus snake venom, a delta- and kappa-opioid receptor agonist.
Picolo G; Cury Y
Life Sci; 2004 Jun; 75(5):559-73. PubMed ID: 15158366
[TBL] [Abstract][Full Text] [Related]
13. Endogenous cannabinoid receptor agonist anandamide induces peripheral antinociception by activation of ATP-sensitive K+ channels.
Reis GM; Ramos MA; Pacheco Dda F; Klein A; Perez AC; Duarte ID
Life Sci; 2011 Apr; 88(15-16):653-7. PubMed ID: 21277864
[TBL] [Abstract][Full Text] [Related]
14. Opioid receptor and NO/cGMP pathway as a mechanism of peripheral antinociceptive action of the cannabinoid receptor agonist anandamide.
Reis GM; Pacheco D; Perez AC; Klein A; Ramos MA; Duarte ID
Life Sci; 2009 Aug; 85(9-10):351-6. PubMed ID: 19576231
[TBL] [Abstract][Full Text] [Related]
15. The kappa-opioid agonist (+/-)-bremazocine elicits peripheral antinociception by activation of the L-arginine/nitric oxide/cyclic GMP pathway.
Amarante LH; Duarte ID
Eur J Pharmacol; 2002 Nov; 454(1):19-23. PubMed ID: 12409000
[TBL] [Abstract][Full Text] [Related]
16. α
Romero TRL; Miranda E Castor MG; Parrella C; Piscitelli F; Di Marzo V; Duarte IDG
Pharmacol Rep; 2020 Feb; 72(1):96-103. PubMed ID: 32016857
[TBL] [Abstract][Full Text] [Related]
17. Probable involvement of alpha(2C)-adrenoceptor subtype and endogenous opioid peptides in the peripheral antinociceptive effect induced by xylazine.
Romero TR; de Castro Perez A; de Francischi JN; Gama Duarte ID
Eur J Pharmacol; 2009 Apr; 608(1-3):23-7. PubMed ID: 19236861
[TBL] [Abstract][Full Text] [Related]
18. Involvement of ATP-sensitive K(+) channels in the peripheral antinociceptive effect induced by the alpha(2)-adrenoceptor agonist xylazine.
Romero TR; Duarte ID
J Pharmacol Sci; 2009 Dec; 111(4):323-7. PubMed ID: 20019444
[TBL] [Abstract][Full Text] [Related]
19. Mu, delta, and kappa opioid receptor agonists induce peripheral antinociception by activation of endogenous noradrenergic system.
Romero TR; Guzzo LS; Duarte ID
J Neurosci Res; 2012 Aug; 90(8):1654-61. PubMed ID: 22473744
[TBL] [Abstract][Full Text] [Related]
20. Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors.
Romero TR; Pacheco Dda F; Duarte ID
Life Sci; 2013 May; 92(14-16):815-20. PubMed ID: 23123446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
